Accessibility Menu
Cardiff Lexington logo

Cardiff Lexington(OTC) CDIX

Current PriceN/A
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-100%
5 Year-100%
1 Year-84%
1 Month-64%
Cardiff Lexington last closing stock price
MetricPriceDate
Last closeUSD 0.642026-07-23
Cardiff Lexington stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-48.8%USD 1.252026-07-15
1 month-64.44%USD 1.802026-06-22
3 month-65.78%USD 1.872026-04-24
Year to date-88.62%USD 5.622025-12-31
1 year-84.31%USD 4.082025-07-22
3 year-98.54%USD 43.882023-07-24
5 year-99.97%USD 2,025.002021-07-23
Since inception-100%USD 3,745,318.352004-07-19

Cardiff Lexington Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$10.84M

Net Income (TTM)

-$9.18M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 18, 2025

CDIX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiff Lexington

Cardiff Lexington helps people access orthopedic healthcare and affordable housing. It provides medical care for injury victims and manages real estate for future development. The company supports those needing specialized care or alternative housing options.

Products and Services

  • Orthopedic Healthcare (100% revenue): Diagnostic and surgical care for injury victims, mainly in Florida.
  • Pain Management: Interventional treatments for pain, often for uninsured or underinsured patients.
  • Letter of Protection Services: Medical care provided with payment from insurance settlements, not upfront by patients.
  • Real Estate Holdings (0% revenue): Land in Idaho for planned residential development, not yet generating income.
  • Tax Resolution Services: Bookkeeping and tax help for individuals and businesses with tax debts.

Growth and Expansion

  • Acquired Nova Ortho and Spine in 2021, expanding into healthcare services.
  • Acquired Edge View Properties in 2014, adding Idaho real estate assets.
  • Increased credit facility to $15 million in December 2024 to support operations.
  • Plans joint venture for Idaho land development, with no new product launches reported.

What Makes Cardiff Lexington Stand Out

The company focuses on niche healthcare, serving patients who often lack insurance. Its "letter of protection" model reduces credit risk by collecting payments from legal settlements. Cardiff Lexington keeps prior owners involved to maintain operational expertise after acquisitions.

Five Things You Need to Know

  • Revenue was $2.8 million in Q2 2025, up 89.5% from Q2 2024.
  • Gross profit margin rose to 60.8% in Q2 2025 from 46.1% in Q2 2024.
  • Net loss was $1.2 million in Q2 2025, compared to $0.1 million in Q2 2024.
  • Healthcare segment made up 100% of revenue in Q2 2025.

Bottom Line

Cardiff Lexington has shifted from real estate to healthcare, focusing on specialized patient care. The company faces ongoing losses but continues to adapt its business model.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

18

CEO

Alex H. Cunningham, MBA

Website

www.cardifflexington.com

Headquarters

Fort Lauderdale, FL 33301, US

CDIX Financials

Key Financial Metrics (TTM)

Gross Margin

61.65%

Operating Margin

0.42%

Net Income Margin

-84.70%

Return on Equity

-216.46%

Return on Capital

4.50%

Return on Assets

-30.32%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-3.35%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$6.68M

Operating Income

$45.49K

EBITDA

-$1.05M

Operating Cash Flow

-$3.52M

Capital Expenditure

$3.00

Free Cash Flow

-$3.52M

Cash & ST Invst.

$683.51K

Total Debt

$20.76M

Cardiff Lexington Performance Analysis

Cardiff Lexington annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 10,693,1968.2%
20232023-12-31USD 11,853,26610.8%
20242024-12-31USD 8,270,126-30.2%
20252025-12-31USD 11,535,57739.5%
Cardiff Lexington sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-4.3%
Q32025-09-309.7%
Q42025-12-31-9.4%
Q12026-03-31-19.8%
Cardiff Lexington annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2,920.50N/A
20232023-12-31USD 454.50N/A
20242024-12-31USD -1.09N/A
20252025-12-31USD -0.98-10.1%
Cardiff Lexington sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-73.4%
Q32025-09-3011.3%
Q42025-12-31-90.5%
Q12026-03-3142.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.22M

-23.8%

Gross Profit

$1.32M

-28.4%

Gross Margin

59.31%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

15

N/A

Net Income

-$3.09M

-585.9%

EBITDA

-$510.57K

-193.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$683.51K

-31.4%

Total Debt

$20.76M

+84.6%

Accounts Receivable

$22.89M

+30.8%

Inventory

$0.00

N/A

Long Term Debt

$271.97K

-19.4%

Short Term Debt

$20.49M

+87.8%

Return on Assets

-30.32%

N/A

Return on Invested Capital

0.77%

N/A

Free Cash Flow

-$16.73K

+96.6%

Operating Cash Flow

-$16.73K

+96.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OFSTFCarbon Streaming Corporation
$0.66+6.31%
BKFGBKF Capital Group, Inc.
$94.00+0.00%
CBTTFCathedra Bitcoin Inc.
$0.46+25.16%
TETAAAlpha G Investment Management, Inc.
$15.00+5.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
TAT&T
$24.13+0.05%
FFord Motor Company
$14.37+0.02%

Questions About CDIX

What is the current price of Cardiff Lexington?

Cardiff Lexington is trading at N/A per share.

What is the 52-week range for Cardiff Lexington?

Over the past 52 weeks, Cardiff Lexington has traded between N/A and N/A.

How much debt does Cardiff Lexington have?

As of the most recent reporting period, Cardiff Lexington reported total debt of $20.76M.

How much cash does Cardiff Lexington have on hand?

Cardiff Lexington reported $683.51K in cash and cash equivalents in its most recent financial results.

What is Cardiff Lexington’s dividend yield?

Cardiff Lexington does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services